MedPath

Orphenadrine Citrate

Orphenadrine Citrate

Approved
Approval ID

91436f1e-8b05-435c-e053-2a95a90ae21f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2024

Manufacturers
FDA

Direct_Rx

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Orphenadrine Citrate

PRODUCT DETAILS

NDC Product Code61919-177
Application NumberANDA040284
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 9, 2024
Generic NameOrphenadrine Citrate

INGREDIENTS (4)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
ORPHENADRINE CITRATEActive
Quantity: 100 mg in 1 1
Code: X0A40N8I4S
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Orphenadrine Citrate - FDA Approval | MedPath